Article
Primary Signet Ring Cell/Histiocytoid Carcinoma of the Eyelid: Somatic Mutations in CDH1 and Other Clinically Actionable Mutations Imply Early Use of Targeted Agents.
Current oncology (Toronto, Ont.) - 16 Feb 2021
Wang Lei-Chi, Lin Tai-Chi, Yeh Yi-Chen, Ho Hsiang-Ling, Tsai Chieh-Chih, Chou Teh-Ying
Abstract excerpt
Primary signet ring cell/histiocytoid carcinoma of the eyelid is a rare ocular malignancy and its diagnosis is often delayed. This neoplasm presents as an insidious, diffusely infiltrative mass in the periocular area that later infiltrates the orbit. An exenteration is usually indicated; however, nearly one-third of patients develop local recurrence or metastasis. Morphologically, it resembles signet ring cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
